MultiSpectral Imaging System for Rheumatoid Arthritis

University of Rochester, Rochester, NY
Rheumatoid ArthritisMultiSpectral Imaging System - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is examining the progression of RA and the effectiveness of clinical interventions using NIR-ICG imaging, which is a reliable and reproducible method.

Eligible Conditions
  • Rheumatoid Arthritis

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase 1

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 16 weeks

1 week post injection
Clearance
16 weeks
Contraction Rate
Lymphatic Vessels

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Established RA (> 10 years of disease)
1 of 2
Early RA (<1 year of disease)
1 of 2

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: MultiSpectral Imaging System · No Placebo Group · Phase 1

Established RA (> 10 years of disease)Experimental Group · 2 Interventions: Indocyanine green, MultiSpectral Imaging System · Intervention Types: Drug, Device
Early RA (<1 year of disease)Experimental Group · 2 Interventions: Indocyanine green, MultiSpectral Imaging System · Intervention Types: Drug, Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Indocyanine green
2016
Completed Phase 3
~1520
MultiSpectral Imaging System
2019
Completed Phase 1
~30

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 16 weeks

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,550 Previous Clinical Trials
24,611,105 Total Patients Enrolled
9 Trials studying Rheumatoid Arthritis
610 Patients Enrolled for Rheumatoid Arthritis
University of RochesterLead Sponsor
807 Previous Clinical Trials
506,609 Total Patients Enrolled
5 Trials studying Rheumatoid Arthritis
68 Patients Enrolled for Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
457 Previous Clinical Trials
1,084,545 Total Patients Enrolled
42 Trials studying Rheumatoid Arthritis
558,434 Patients Enrolled for Rheumatoid Arthritis
Christopher Ritchlin, MD, MPHPrincipal InvestigatorUniversity of Rochester

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have recently been diagnosed with rheumatoid arthritis (RA).
You have had the disease for a year or less.

Frequently Asked Questions

Is the research team engaging in patient recruitment for this trial?

"According to the information on clinicaltrials.gov, this experiment is currently not recruiting participants. It was first posted on December 30th 2021 and modified most recently January 20th 2022. Despite no open recruitment for this study at present, there are 379 other trials actively enrolling patients at this time." - Anonymous Online Contributor

Unverified Answer

Has the MultiSpectral Imaging System earned regulatory approval by the FDA?

"In accordance with the data provided from our organisation, Power, the MultiSpectral Imaging System is estimated to be of a low level safety rating (1), given that this study is in its first phase and there are limited clinical trials demonstrating efficacy." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.